John N. Allan, MD

Use of Novel Prognostic Markers in Practice for CLL

John N. Allan , MD;

03/09/2020

Novel Agent Combinations: Is this the final answer?

John N. Allan , MD;

10/25/2019

Assessing the Therapeutic Options for Richter’s Syndrome

John N. Allan , MD;

10/19/2018

Videos

Analyzing the Role of BTK Inhibitors and Combination Therapies in the Frontline Treatment of Patients With CLL

08/18/2023

John N. Allan , MD;

At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting, John Allan, MD, analyzes the role of BTK inhibitors and combination therapies in the frontline treatment of patients with chronic lymphocytic leukemia.

At the 2023 Great Debates &...

08/18/2023

Oncology

Sequencing Decisions Using Current Therapy Options for CLL

John N. Allan , MD;

03/10/2020

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

John N. Allan, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products